ArticleAdvances in therapy2024

Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma.

Hermann Einsele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.